Fabre-Kramer Pharmaceuticals
TypeS Corporation
IndustryPharmaceuticals
Founded1992
HeadquartersHouston, Texas
Key people
Stephen Kramer (CEO) Ed Koehler (Executive Vice President, CFO)
ProductsTravivo (Gepirone ER), FKB01MD, FKW00GA, FKF02SC, FKK01PD
Websitewww.fabrekramer.com

Fabre-Kramer Pharmaceuticals is a pharmaceutical company that specializes in the development of psychotropic drugs. Products in their current development pipeline include gepirone and FKB01MD for major depression, gepirone and FKW00GA for social anxiety disorder,[1] gepirone for hypoactive sexual desire disorder, FKF02SC for schizophrenia, and FKK01PD for Parkinson's disease.[2]

The company has also conducted clinical studies on a gepirone extended release formulation for major depression.[3][4][5]

In 2007, Fabre-Kramer Pharmaceuticals along with GlaxoSmithKline (GSK) received a 'not approvable' letter from the US Food and Drug Administration, for a gepirone extended release drug, an antidepressant treatment for adults.[6]

References

  1. ↑ "Pipeline – Fabre-Kramer Pharmaceuticals, Inc". Archived from the original on March 30, 2023. Retrieved 2023-03-30.
  2. ↑ "Product Pipeline". Fabre Kramer Pharmaceuticals. Archived from the original on 2011-11-11. Retrieved 2011-10-16.
  3. ↑ Fabre LF, Smith LC (August 2011). "The Effect of Major Depression on Sexual Function in Women". J Sex Med. 9 (1): 231–9. doi:10.1111/j.1743-6109.2011.02445.x. PMID 21883948.
  4. ↑ Fabre LF, Smith LC, DeRogatis LR (September 2011). "Gepirone-ER treatment of low sexual desire associated with depression in women as measured by the DeRogatis Inventory of Sexual Function (DISF) fantasy/cognition (desire) domain--a post hoc analysis". J Sex Med. 8 (9): 2569–81. doi:10.1111/j.1743-6109.2011.02330.x. PMID 21707926.
  5. ↑ Fabre LF, Brown CS, Smith LC, Derogatis LR (May 2011). "Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women". J Sex Med. 8 (5): 1411–9. doi:10.1111/j.1743-6109.2011.02216.x. PMID 21324094.
  6. ↑ Lewcock, Anna (November 5, 2007). "GSK, Fabre-Kramer lose out on antidepressant". outsourcing-pharma.com. Archived from the original on September 10, 2023. Retrieved 2020-05-11.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.